Rare Tumours of the Kidney
Rare malignant neoplasms of the kidney have aggressive outcomes but are not covered in most books of Urology, Surgery, and Medicine. This book focuses on these rare neoplasms, providing updated information on a heterogeneous group of disorders with distinct abnormalities.
Rare types of prostate cancer are aggressive, have poor prognoses, and are often misdiagnosed. This book updates the literature on these rare neoplasms to alert clinicians and encourage research to find more effective treatment options.
Improved cancer survival has led to a new challenge: a rise in second primary cancers. As survivors live longer, understanding these malignancies is essential for follow-up care. This book provides insights into the epidemiology, risk factors, and management of these new cancers.
Survival after Treatment for Gynaecological Cancer
As gynaecological cancer survival rates improve, quality of life after treatment is vital. This is the first textbook on managing the physical and psychological effects of treatment. It is essential reading for gynaecological oncology specialists and related disciplines.
This book uses a systems biology approach to understand complex cancers. It analyzes cellular networks to identify key biomarkers for drug targets, and presents the design of a multiple-molecule drug for therapeutic treatment with fewer side effects.
Public fear of breast cancer obscures the facts. Treatments can increase other health risks, while fear itself can impair quality of life. This book explores the history and mystery of breast cancer, from Ancient Egypt to the future, to champion the totality of women’s health.
This book highlights the usefulness of magnetic resonance imaging (MRI) for lung and thoracic tumors. Economical and with no radiation exposure, MRI offers advantages over CT and PET-CT, allowing for qualitative analysis of disease and early assessment of therapeutic effects.
For patients with metastatic cancer, the prognosis remains grim and conventional chemotherapy is limited. This book lays out a novel strategy using artificial intelligence and genomic data to develop precise, personalized treatments that offer hope for an eventual cure.